drugset / Trial / NCT06681805
Prophylactic Mirtazapine and Different Doses of Intrathecal Morphine in Preventing Nausea and Vomiting After Cesarean Section
RandomizedParallel-groupDouble-blindPrevention
Summary
The aim of this work was to evaluate the role of prophylactic mirtazapine and different doses of intrathecal morphine in preventing nausea and vomiting.
Timeline
- Start
- 2023-01-01
- Primary completion
- 2024-09-25
- Completion
- 2024-09-25
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Mirtazapine | Other / unclassified | 30 mg | Oral |
| Subject | Morphine | Other / unclassified | 0.1 mg | Intrathecal |
| Subject | Morphine | Other / unclassified | 0.2 mg | Intrathecal |
| Background | Bupivacaine | Other / unclassified | 10 mg | — |
Indications
No indication recorded.